Literature DB >> 10393860

Human cytomegalovirus infection decreases expression of thrombospondin-1 independent of the tumor suppressor protein p53.

J Cinatl1, R Kotchetkov, M Scholz, J Cinatl1, J U Vogel, P H Driever, H W Doerr.   

Abstract

Thrombospondin-1 (TSP-1) is a potent inhibitor of angiogenesis. It has been shown that promoter sequences of the TSP-1 gene can be transactivated by the wild-type tumor suppressor protein p53. As human cytomegalovirus (HCMV) infection inactivates wild-type p53 of various cell types, we investigated whether HCMV infection is associated with reduced TSP-1 production. We found, in conjunction with accumulated p53, that TSP-1 mRNA and protein expression was significantly reduced in HCMV-infected cultured human fibroblasts. To determine whether the observed TSP-1 suppression depends on p53 inactivation, the p53-defective astrocytoma cell line U373MG was infected with HCMV. In these cells TSP-1 expression was also significantly reduced by HCMV infection whereas expression of the p53 mutant variant remained unaltered. In both cell lines the decreased expression of TSP-1 mRNA occurred early after infection (4 hours), indicating that HCMV inhibits TSP-1 transcription during the immediate-early phase of infection before HCMV DNA replication. Inhibition of HCMV DNA synthesis by ganciclovir did not influence TSP-1 reduction whereas the antisense oligonucleotide ISIS 2922, complementary to HCMV immediate-early mRNA, completely prevented the HCMV-mediated TSP-1 suppression. These findings strongly suggest a novel role for HCMV in the modulation of angiogenesis due to p53-independent down-regulation of TSP-1 expression.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10393860      PMCID: PMC1866648          DOI: 10.1016/S0002-9440(10)65122-X

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  47 in total

1.  Release of an inhibitor of angiogenesis upon induction of wild type p53 expression in glioblastoma cells.

Authors:  E G Van Meir; P J Polverini; V R Chazin; H J Su Huang; N de Tribolet; W K Cavenee
Journal:  Nat Genet       Date:  1994-10       Impact factor: 38.330

Review 2.  Fibroblast growth factors and their receptors: an information network controlling tissue growth, morphogenesis and repair.

Authors:  D G Fernig; J T Gallagher
Journal:  Prog Growth Factor Res       Date:  1994

3.  Cytomegalovirus infection induces high levels of cyclins, phosphorylated Rb, and p53, leading to cell cycle arrest.

Authors:  F M Jault; J M Jault; F Ruchti; E A Fortunato; C Clark; J Corbeil; D D Richman; D H Spector
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

4.  Long-term productive human cytomegalovirus infection of a human neuroblastoma cell line.

Authors:  J Cinatl; J U Vogel; J Cinatl; B Weber; H Rabenau; M Novak; B Kornhuber; H W Doerr
Journal:  Int J Cancer       Date:  1996-01-03       Impact factor: 7.396

5.  Overlapping Egr-1 and Sp1 sites function in the regulation of transcription of the mouse thrombospondin 1 gene.

Authors:  T Shingu; P Bornstein
Journal:  J Biol Chem       Date:  1994-12-23       Impact factor: 5.157

6.  Thrombospondin inhibits adhesion of endothelial cells.

Authors:  J Lahav
Journal:  Exp Cell Res       Date:  1988-07       Impact factor: 3.905

7.  Human cytomegalovirus IE1 and IE2 proteins block apoptosis.

Authors:  H Zhu; Y Shen; T Shenk
Journal:  J Virol       Date:  1995-12       Impact factor: 5.103

8.  Transfection of thrombospondin 1 complementary DNA into a human breast carcinoma cell line reduces primary tumor growth, metastatic potential, and angiogenesis.

Authors:  D L Weinstat-Saslow; V S Zabrenetzky; K VanHoutte; W A Frazier; D D Roberts; P S Steeg
Journal:  Cancer Res       Date:  1994-12-15       Impact factor: 12.701

9.  Control of angiogenesis in fibroblasts by p53 regulation of thrombospondin-1.

Authors:  K M Dameron; O V Volpert; M A Tainsky; N Bouck
Journal:  Science       Date:  1994-09-09       Impact factor: 47.728

10.  SPARC and thrombospondin genes are repressed by the c-jun oncogene in rat embryo fibroblasts.

Authors:  A Mettouchi; F Cabon; N Montreau; P Vernier; G Mercier; D Blangy; H Tricoire; P Vigier; B Binétruy
Journal:  EMBO J       Date:  1994-12-01       Impact factor: 11.598

View more
  20 in total

Review 1.  Is HCMV a tumor promoter?

Authors:  Liliana Soroceanu; Charles S Cobbs
Journal:  Virus Res       Date:  2010-10-29       Impact factor: 3.303

2.  How does cytomegalovirus factor into diseases of aging and vaccine responses, and by what mechanisms?

Authors:  Allison E Aiello; Yen-Ling Chiu; Daniela Frasca
Journal:  Geroscience       Date:  2017-06-18       Impact factor: 7.713

3.  Expression of insulin-like growth factor binding protein-2 (IGFBP-2) gene in negative and positive human cytomegalovirus glioblastoma multiforme tissues.

Authors:  Narges Ahani; Mohsen Karimi Arzenani; Reza Shirkoohi; Mohammad Rokouei; Majid Alipour Eskandani; Abbas Nikravesh
Journal:  Med Oncol       Date:  2013-12-19       Impact factor: 3.064

Review 4.  Invoking the power of thrombospondins: regulation of thrombospondins expression.

Authors:  Olga Stenina-Adognravi
Journal:  Matrix Biol       Date:  2014-02-25       Impact factor: 11.583

5.  Human cytomegalovirus infection of tumor cells downregulates NCAM (CD56): a novel mechanism for virus-induced tumor invasiveness.

Authors:  Roman A Blaheta; Wolf-Dietrich Beecken; Tobias Engl; Dietger Jonas; Elsie Oppermann; Michael Hundemer; Hans Wilhelm Doerr; Martin Scholz; Jindrich Cinatl
Journal:  Neoplasia       Date:  2004 Jul-Aug       Impact factor: 5.715

6.  Elongation factor ELL (Eleven-Nineteen Lysine-rich Leukemia) acts as a transcription factor for direct thrombospondin-1 regulation.

Authors:  Jiangang Zhou; Xi Feng; Bin Ban; Jingxia Liu; Zhou Wang; Wuhan Xiao
Journal:  J Biol Chem       Date:  2009-05-15       Impact factor: 5.157

7.  Sensitive detection of human cytomegalovirus in tumors and peripheral blood of patients diagnosed with glioblastoma.

Authors:  Duane A Mitchell; Weihua Xie; Robert Schmittling; Chris Learn; Allan Friedman; Roger E McLendon; John H Sampson
Journal:  Neuro Oncol       Date:  2007-10-19       Impact factor: 12.300

Review 8.  Chronic viral infection and primary central nervous system malignancy.

Authors:  Robert Saddawi-Konefka; John R Crawford
Journal:  J Neuroimmune Pharmacol       Date:  2010-04-13       Impact factor: 4.147

Review 9.  The story of human cytomegalovirus and cancer: increasing evidence and open questions.

Authors:  Martin Michaelis; Hans W Doerr; Jindrich Cinatl
Journal:  Neoplasia       Date:  2009-01       Impact factor: 5.715

10.  Tumor suppressor U19/EAF2 regulates thrombospondin-1 expression via p53.

Authors:  F Su; L E Pascal; W Xiao; Z Wang
Journal:  Oncogene       Date:  2009-10-12       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.